Prostate Cancer

The addition of custirsen did not improve survival for a subset of patients with prostate cancer in a phase 3 trial.

Randy F. Sweis talks to CURE about the future of treatment for GU cancers.

CURE spoke with Celestia S. Higano on common problems that survivors of prostate cancer face.

Gregory Zagaja discusses the benefits of surgery for prostate cancer, as well as recent updates in the field.

Stanley Liauw discusses the current and future role of radiation therapy for patients with prostate cancer.

A new online tool can help patients with prostate cancer determine if active surveillance is the right decision.

CURE spoke with Akash Patnaik about immunotherapy's role in prostate cancer.

When Gilbert Eugene Crawford, Sr. was diagnosed with prostate cancer, his daughter and primary caregiver Valerie Crawford-Schiele was shocked to discover just how few resources existed for patients with prostate cancer and their caregivers.

Previous studies have shown the benefit yoga has for women with breast cancer, but a recent study also showed that the activity has potential benefits for men with prostate cancer as well.

Bone metastases often create significant problems for patients with advanced prostate cancer, according to Neal Shore.

"The Prostate Cancer Research Institute, (PCRI), a 501(c)(3) not-for-profit organization, mission is to improve the quality of prostate cancer patients and caregivers lives by supporting research and disseminating information that educates and empowers patients, families and the medical community."

Researchers are hopeful about the potential for a novel agent in high-risk prostate cancer.

Patients treated with Xtandi had higher rates of fatigue and pain than those who were treated with Zytiga and prednisone, resulting in a higher likelihood that they will reduce their treatment dose.

This research was presented at the 2016 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of over 30,000 oncology professionals in Chicago.

Patients with early-stage prostate cancer may be able to shorten their radiation time, thanks to the results of a recent study conducted by the Duke Cancer Institute.

A life-saving therapy for patients with prostate cancer may cause clinical depression, according to a recent study.

Several new tests for prostate cancer are on the market. When used alongside PSA screenings, they can provide a much more straightforward insight into prostate cancer risk.

It is crucial to know all the side effects of the medication and surgeries you receive before starting cancer treatment.

As medical advances continue, the Prostate Cancer Foundation is determined to find a cure for the disease.